The evidence-based treatments for OUD are medications — buprenorphine, methadone, naltrexone — with decades of mortality data behind them. Cannabis is not a treatment for opioid use disorder, and federal agencies are explicit about that. The harm-reduction hypothesis — cannabis easing withdrawal symptoms, cravings, or serving as a less lethal substitute — has observational support and active research interest (NIDA funds it), but the causal record remains unsettled, with some studies showing worse OUD outcomes among cannabis users.
If you're considering this pathway: pair it with actual treatment. The defensible role is adjunct comfort — sleep, anxiety, pain during medication-assisted treatment — under physicians who know your full picture. Anyone selling cannabis as the way off opioids without MOUD is selling mortality risk.
The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law.